Status:
UNKNOWN
Wenzhou Dry Age-related Macular Degeneration (AMD) Progression Study
Lead Sponsor:
The Eye Hospital of Wenzhou Medical University
Conditions:
Macular Pigment Optical Density
Eligibility:
All Genders
45+ years
Brief Summary
To evaluate the correlation between macular pigment optical density (MPOD) levels and risk of progression in patients with age-related macular degeneration
Detailed Description
Age-related macular degeneration (AMD) is the leading cause of blindness in the elderly.\[1\] The disease is categorized into early, intermediate, or advanced stages based on the severity of symptoms....
Eligibility Criteria
Inclusion
- subject is diagnosed with either CNV, dry AMD
- 45 years of age or older
- provides signed and dated informed consent
Exclusion
- Ocular condition in the study eye which may impact vision and confound study outcomes
- Presence of macular edema like retinal vascular diseases or diabetic retinopathy
- active inflammation ofr infection in the study eye
- high myopia（ ≥6D ）
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03433885
Start Date
January 1 2018
End Date
December 31 2023
Last Update
February 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The eye hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China, 325000